ADIPOQ and chronic kidney disease: Several studies in non-CKD patients have demonstrated increased adiponectin levels with weight loss, physical exercise and the use of pharmacological agents, including angiotensin converting enzyme inhibitors, angiotensin 2 receptor blockers, statins and thiazolidinediones [40-42].